| Gene symbol | tk |
| GTO ID | GTC1265 |
| Trial ID | NCT00415454 |
| Disease | Pancreatic Cancer |
| Altered gene | yCD|tk |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | DNA oncolytic virus |
| Treatment | Ad5-yCD/mutTKSR39rep-ADP |
| Co-treatment | 5-fluorocytosine|valganciclovir |
| Phase | Phase1 |
| Recruitment status | Terminated |
| Title | Phase I Study Combining Replication-Competent Adenovirus-Mediated Suicide Gene Therapy With Chemoradiotherapy for the Treatment of Non-Metastatic Pancreatic Adenocarcinoma |
| Year | 2006 |
| Country | United States |
| Company sponsor | Henry Ford Health System |
| Other ID(s) | Panc4242|P01CA097012 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||